- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-20
DOI
10.3389/fcvm.2021.644095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients
- (2021) Thirumalaisamy P. Velavan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
- (2021) Claire Lugnier et al. BIOCHEMICAL PHARMACOLOGY
- COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
- (2021) Hayder M. Al-kuraishy et al. Frontiers in Medicine
- Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
- (2021) Hayder M. Al-kuraishy et al. Frontiers in Cardiovascular Medicine
- AMP-Activated Protein Kinase Restricts Zika Virus Replication in Endothelial Cells by Potentiating Innate Antiviral Responses and Inhibiting Glycolysis
- (2020) Sneha Singh et al. JOURNAL OF IMMUNOLOGY
- Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies
- (2020) Dawit Zewdu Wondafrash et al. Journal of Diabetes Research
- Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes
- (2020) Christian D. Becker et al. AMERICAN JOURNAL OF MEDICINE
- What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?
- (2020) Thadathilankal-Jess John et al. CANADIAN JOURNAL OF CARDIOLOGY
- Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
- (2020) Huihui Ren et al. Cardiovascular Diabetology
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed
- (2020) Aihong Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- COVID-19, diabetes mellitus and ACE2: The conundrum
- (2020) Rimesh Pal et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics
- (2020) Ernesto Maddaloni et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Managing People with Diabetes Fasting for Ramadan During the COVID‐19 Pandemic: A South Asian Health Foundation Update
- (2020) S. Hanif et al. DIABETIC MEDICINE
- Diabetes and COVID-19: evidence, current status and unanswered research questions
- (2020) Ritesh Gupta et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Pancreatic injury patterns in patients with COVID-19 pneumonia
- (2020) Fan Wang et al. GASTROENTEROLOGY
- Effects of Sulfonylureas on Periodontopathic Bacteria-Induced Inflammation
- (2020) Y. Kawahara et al. JOURNAL OF DENTAL RESEARCH
- Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
- (2020) Raymond Pranata et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- The role of adipocytes and adipocyte‐like cells in the severity of COVID‐19 infections
- (2020) Ilja L. Kruglikov et al. Obesity
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
- (2020) Catrin Sohrabi et al. International Journal of Surgery
- COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 ( DPP4 ) in disease severity?
- (2020) Margaret F. Bassendine et al. Journal of Diabetes
- SGLT-2 inhibitors for COVID-19 — A miracle waiting to happen or just another beat around the bush?
- (2020) Subhankar Chatterjee Primary Care Diabetes
- Prevalence and impact of diabetes among people infected with SARS-CoV-2
- (2020) G. P. Fadini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Renal denervation improves vascular endothelial dysfunction by inducing autophagy via AMPK/mTOR signaling activation in a rat model of type 2 diabetes mellitus with insulin resistance
- (2020) Yong Wang et al. ACTA DIABETOLOGICA
- Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
- (2020) Miriam Longo et al. Cardiovascular Diabetology
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy
- (2020) Ernesto Maddaloni et al. DIABETES CARE
- Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study
- (2020) Yumin Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin in COVID-19: A possible role beyond diabetes
- (2020) Swati Sharma et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
- (2020) Bingwen Liu et al. JOURNAL OF AUTOIMMUNITY
- Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome
- (2020) Loris Roncon et al. JOURNAL OF CLINICAL VIROLOGY
- Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?
- (2020) Elena Carboni et al. MEDICAL HYPOTHESES
- In vitro and in vivo identification of clinically approved drugs that modify ACE 2 expression
- (2020) Sanju Sinha et al. Molecular Systems Biology
- Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)
- (2020) Antonio F. Saad et al. OBSTETRICS AND GYNECOLOGY
- Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
- (2020) Kui K. Chan et al. SCIENCE
- Factors Leading to High Morbidity and Mortality of COVID ‐19 in Patients with Type 2 Diabetes
- (2020) Aman Rajpal et al. Journal of Diabetes
- Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature
- (2020) Philippe Oriot et al. ACTA CLINICA BELGICA
- DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
- (2020) Inés Valencia et al. Frontiers in Pharmacology
- Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
- (2020) Syed Shahzad Hasan et al. Expert Review of Respiratory Medicine
- Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
- (2020) Bhawna Attri et al. Diabetes Therapy
- The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
- (2020) Pere Domingo et al. EBioMedicine
- The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
- (2020) Yu Li et al. iScience
- Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors
- (2020) Jalal Taneera et al. Biology-Basel
- Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19
- (2020) Chang Li et al. Aging-US
- SARS-CoV-2 leading to acute pancreatitis: an unusual presentation
- (2020) Amanda Mandarino Alves et al. Brazilian Journal of Infectious Diseases
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
- (2020) Marco Mirani et al. DIABETES CARE
- Hyperglycemia and COVID-19: What was known and what is really new?
- (2020) Antonio Ceriello DIABETES RESEARCH AND CLINICAL PRACTICE
- Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
- (2020) Awadhesh Kumar Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS‐CoV‐2 outbreak in type 1 diabetes
- (2020) Irene Caruso et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases
- (2020) Ravindra K. Sharma et al. HYPERTENSION
- COVID-19 in people living with diabetes: An international consensus
- (2020) A.E. Caballero et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients
- (2020) William B. Klimstra et al. JOURNAL OF GENERAL VIROLOGY
- Clinical characteristics and humoral immune response in Healthcare Workers with COVID-19 in a Teaching Hospital in Belgium
- (2020) G. Vandercam et al. JOURNAL OF HOSPITAL INFECTION
- COVID‑19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review)
- (2020) Radu Albulescu et al. Experimental and Therapeutic Medicine
- Newly diagnosed diabetes in COVID-19 patients
- (2020) Thirunavukkarasu Sathish et al. Primary Care Diabetes
- The Inflammasome in Times of COVID-19
- (2020) Juan Carlos de Rivero Vaccari et al. Frontiers in Immunology
- Diabetes, infection risk and COVID-19
- (2020) Suheda Erener Molecular Metabolism
- Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
- (2020) Dimitrios Patoulias et al. Diabetes Therapy
- Covid-19 and Diabetes: A Complex Bidirectional Relationship
- (2020) Hermine Muniangi-Muhitu et al. Frontiers in Endocrinology
- SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
- (2020) Katie C. Coate et al. Cell Metabolism
- The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection
- (2020) Laszlo Göbölös et al. JOURNAL OF VASCULAR SURGERY
- Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors
- (2019) Susan J. Bersoff-Matcha et al. ANNALS OF INTERNAL MEDICINE
- Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2019) Guangyao Li et al. DIABETES CARE
- Clinical Use of DPP-4 Inhibitors
- (2019) Baptist Gallwitz Frontiers in Endocrinology
- ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue
- (2019) Yasuhiro Kawabe et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis
- (2019) Gábor Kökény et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis
- (2018) Srilaxmi Kalavalapalli et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Metformin alleviated endotoxemia-induced acute lung injury via restoring AMPK-dependent suppression of mTOR
- (2018) Kejia Wu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection
- (2018) Ronghua Hu et al. CLINICAL IMMUNOLOGY
- A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials
- (2018) Carolyn F. Deacon DIABETES OBESITY & METABOLISM
- Interleukin-37 Treatment of Mice with Metabolic Syndrome Improves Insulin Sensitivity and Reduces Pro-inflammatory Cytokine Production in Adipose Tissue
- (2018) Dov B Ballak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dipeptidyl peptidase-4 inhibitors-associated bullous pemphigoid: a retrospective study of 168 pemphigoid and 9,304 diabetes mellitus cases
- (2018) Yohei Kawaguchi et al. Journal of Diabetes Investigation
- ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus
- (2018) Cheng Liu et al. Cardiovascular Diabetology
- Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors
- (2018) Mohammed S. Abdel-Maksoud et al. MEDICINAL RESEARCH REVIEWS
- Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations
- (2018) Fahaid Al-Hashem et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sodium-glucose cotransporter inhibitors and oxidative stress: An update
- (2018) Habib Yaribeygi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Exenatide suppresses 1,2-dimethylhydrazine-induced colon cancer in diabetic mice: Effect on tumor angiogenesis and cell proliferation
- (2016) Mona K. Tawfik et al. BIOMEDICINE & PHARMACOTHERAPY
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
- (2009) Jin-Kui Yang et al. ACTA DIABETOLOGICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started